Status:
RECRUITING
Screening Program for Type 1 Diabetes in a High-Risk Population
Lead Sponsor:
King Saud University
Collaborating Sponsors:
Sanofi
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
2-18 years
Brief Summary
Type 1 diabetes mellitus (T1D) is a growing public health concern in Saudi Arabia, ranking ninth globally in T1D incidence and tenth in T1D prevalence in children, and the rates are expected to rise a...
Eligibility Criteria
Inclusion
- T1D diagnosis in a first-degree relative:
- Diabetes is defined based on the American diabetes association (ADA) definition: Classic symptoms of diabetes or hyperglycemic crisis, with plasma glucose concentration ≥11.1 mmol/L (200 mg/dL), or Fasting plasma glucose ≥7.0 mmol/L (≥126 mg/dL). Fasting is defined as no caloric intake for at least 8 h, or Two-hour post load glucose ≥11.1 mmol/L (≥200 mg/dL) during an OGTT, or HbA1c \>6.5%.
Exclusion
- first-degree relative case with Maturity-Onset Diabetes of the Young (MODY) or Type 2 Diabetes Mellitus (T2DM).
- Non-Saudi children.
- first-degree relative not following at our centre.
Key Trial Info
Start Date :
May 26 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2029
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT06513247
Start Date
May 26 2024
End Date
May 1 2029
Last Update
July 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University Diabetes Centre at King Saud University Medial CIty
Riyadh, Saudi Arabia